David Lebovitz
Stock Analyst at Citigroup
(1)
# 1347
Out of 5,298 analysts
126
Total ratings
74.55%
Success rate
9.30%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceutic... | Maintains: Strong Buy | 338 351 | 236.07 | 48.68% | 31 | Mar 21, 2025 | |
MDGL Madrigal Pharmaceuti... | Maintains: Strong Buy | 378 469 | 314.29 | 49.23% | 4 | Feb 27, 2025 | |
BMRN Biomarin Pharmaceuti... | Maintains: Neutral | 81 82 | 60.25 | 36.1% | 3 | Feb 20, 2025 | |
CRNX Crinetics Pharmaceut... | Maintains: Strong Buy | 70 74 | 26.9 | 175.09% | 2 | Nov 14, 2024 | |
MIRM Mirum Pharmaceutical... | Maintains: Strong Buy | 37 38 | 41.97 | -9.46% | 1 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 29 17 | 43.22 | -60.67% | 5 | Oct 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 111 92 | 81.78 | 12.5% | 6 | Feb 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 57 54 | 46.98 | 14.94% | 5 | Aug 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 408 372 | n/a | n/a | 5 | May 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 10 | n/a | n/a | 5 | May 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 38 35 | 27.06 | 29.34% | 6 | May 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 16 17 | 1.06 | 1503.77% | 11 | Apr 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 11 | 1.34 | 720.9% | 7 | Feb 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 193 220 | n/a | n/a | 5 | Feb 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 50 500 | n/a | n/a | 2 | Dec 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 45 44 | n/a | n/a | 10 | Nov 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 194 199 | 142.83 | 39.33% | 11 | Nov 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 510 480 | 3.72 | 12803.23% | 2 | Nov 3, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 27 26 | n/a | n/a | 2 | Aug 13, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 119 129 | n/a | n/a | 3 | Mar 6, 2018 |